Aadi Bioscience, Inc.AADINASDAQ
Loading
AADI Revenue Growth (YoY Quarterly)•-100.00%
Stock Alarm Pro
Growth Metrics
Latest: Q3 2025vs Q2 2025
Revenue GrowthGross Profit GrowthEBITDA GrowthOperating Income GrowthNet Income GrowthEPS GrowthEPS Diluted GrowthWeighted Average Shares GrowthWeighted Average Shares Diluted GrowthDividends per Share Growth
-100.00%
+0.0pp
-100.00%
+0.0pp
+0.00%
+0.0pp
+0.00%
+0.0pp
+0.00%
+0.0pp
+0.00%
+0.0pp
+0.00%
+0.0pp
+179.71%
+23.9pp
+179.71%
+23.9pp
+0.00%
+0.0pp
| Metric | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 |
|---|---|---|---|---|---|
| Revenue Growth | +21.03% | +14.43% | +33.48% | -100.00% | -100.00% |
| Gross Profit Growth | +21.78% | +19.45% | +35.82% | -100.00% | -100.00% |
| EBITDA Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Income Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Net Income Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EPS Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EPS Diluted Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Weighted Average Shares Growth | -8.18% | +0.45% | +46.92% | +155.77% | +179.71% |
| Weighted Average Shares Diluted Growth | -8.18% | +0.45% | +48.00% | +155.77% | +179.71% |
| Dividends per Share Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Cash Flow Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Free Cash Flow Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Receivables Growth | +14.40% | +7.56% | -100.00% | -100.00% | -100.00% |
| Inventory Growth | +51.26% | -17.36% | -100.00% | -100.00% | -100.00% |
| Asset Growth | -38.64% | -46.90% | +110.67% | +77.94% | +94.89% |
| Book Value per Share Growth | -36.54% | -50.34% | +66.83% | -14.62% | -18.41% |
| Debt Growth | -87.47% | -34.25% | -100.00% | -100.00% | -100.00% |
| R&D Expense Growth | -15.92% | +12.37% | -35.35% | +272.79% | +43.49% |
| SG&A Expenses Growth | -35.96% | +6.82% | +20.67% | -24.73% | -27.62% |
1 / 4